# US 2021/0277468 A1 · Safe sequencing system

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0277468 A1
- Document ID: US20210277468A1
- Status: Published application
- Kind: A1
- Application number: 17/324,380
- Filed: 2021-05-19
- Published: 2021-09-09
- Earliest claimed: 2011-04-15
- Assignees: The Johns Hopkins University
- Applicants: The Johns Hopkins University
- Inventors: Bert Vogelstein; Kenneth W. Kinzler; Nickolas Papadopoulos; Isaac A. Kinde
- Web page: https://patentgrep.com/patent/US20210277468A1

## CPC

- C12Q 1/6874: involving nucleic acid arrays, e.g. sequencing by hybridisation
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6869: Methods for sequencing
- C12Q 1/6876: Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q 2525/179: incorporating arbitrary or random nucleotide sequences
- C12Q 2525/191: incorporating an adaptor
- C12Q 2563/179: the label being a nucleic acid
- C12Q 2600/158: Expression markers
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The identification of mutations that are present in a small fraction of DNA templates is essential for progress in several areas of biomedical research. Though massively parallel sequencing instruments are in principle well-suited to this task, the error rates in such instruments are generally too high to allow confident identification of rare variants. We here describe an approach that can substantially increase the sensitivity of massively parallel sequencing instruments for this purpose. One example of this approach, called “Safe-SeqS” for (Safe-Sequencing System) includes (i) assignment of a unique identifier (UID) to each template molecule; (ii) amplification of each uniquely tagged template molecule to create UID-families; and (iii) redundant sequencing of the amplification products. PCR fragments with the same UID are truly mutant (“super-mutants”) if ≥95% of them contain the identical mutation. We illustrate the utility of this approach for determining the fidelity of a polymerase, the accuracy of oligonucleotides synthesized in vitro, and the prevalence of mutations in the nuclear and mitochondrial genomes of normal cells.

## Claims

### Claim 1

(canceled)

### Claim 2

A method to analyze DNA using endogenous unique identifier sequences (UIDs), comprising:
a) attaching adapter oligonucleotides to ends of fragments of analyte DNA of 30 to 2000 bases to form adapted fragments, wherein each end of a fragment before said attaching forms an endogenous UID for the fragment;
b) amplifying said adapted fragments using primers complementary to said adapter oligonucleotides to form a plurality of UID families, wherein each UID family contains at least two family members;
c) redundantly sequencing said at least two family members for each of said plurality of UID families, wherein said redundantly sequencing comprises generating sequencing reads from each of said at least two family members for each of said plurality of UID families;
d) grouping said sequencing reads from each of said plurality of UID families based at least in part on their endogenous UIDs; and
e) identifying a mutation in at least one of said fragments of said analyte DNA when greater than 95% of said sequencing reads from said at least two family members in at least one of said plurality of UID families share an identical mutation.

### Claim 3 (depends on 2)

The method of claim 2, further comprising enriching for fragments representing one or more selected genes by means of capturing a subset of the fragments using capture oligonucleotides complementary to said one or more selected genes in the analyte DNA.

### Claim 4 (depends on 2)

The method of claim 2, further comprising enriching for fragments representing one or more selected genes by means of amplifying fragments complementary to the one or more selected genes.

### Claim 5 (depends on 4)

The method of claim 4, wherein the step of attaching is prior to the step of enriching.

### Claim 6 (depends on 2)

The method of claim 2, wherein said fragments are formed by shearing.

### Claim 7 (depends on 2)

The method of claim 2, wherein each of said plurality of UID families contains at least five family members.

### Claim 8 (depends on 2)

The method of claim 2, wherein each of said plurality of UID families contains at least ten family members.

### Claim 9 (depends on 2)

The method of claim 2, wherein said adapted fragments further comprise exogenous UIDs.

### Claim 10

A method to analyze DNA using endogenous unique identifier sequences (UIDs), comprising:
a) attaching adapter oligonucleotides to ends of fragments of analyte DNA of 30 to 2000 bases to form adapted fragments, wherein each end of a fragment before said attaching forms an endogenous UID for the fragment;
b) amplifying said adapted fragments using primers complementary to said adapter oligonucleotides to form at least two UID families, wherein each UID family contains at least two family members;
c) redundantly sequencing said at least two family members for each of said at least two UID families, wherein said redundantly sequencing comprises generating sequencing reads from each of said at least two family members for each of said at least two UID families;
d) grouping said sequencing reads from each of said at least two UID families based at least in part on their endogenous UIDs; and
e) identifying a mutation in at least one of said fragments of said analyte DNA when greater than 95% of said sequencing reads from said at least two family members in at least one of said at least two UID families share an identical mutation.

### Claim 11 (depends on 10)

The method of claim 10, further comprising enriching for fragments representing one or more selected genes by means of capturing a subset of the fragments using capture oligonucleotides complementary to said one or more selected genes in the analyte DNA.

### Claim 12 (depends on 10)

The method of claim 10, further comprising enriching for fragments representing one or more selected genes by means of amplifying fragments complementary to the one or more selected genes.

### Claim 13 (depends on 12)

The method of claim 12, wherein the step of attaching is prior to the step of enriching.

### Claim 14 (depends on 10)

The method of claim 10, wherein said fragments are formed by shearing.

### Claim 15 (depends on 10)

The method of claim 10, wherein each of said at least two UID families contains at least five family members.

### Claim 16 (depends on 10)

The method of claim 10, wherein each of said at least two UID families contains at least ten family members.

### Claim 17 (depends on 10)

The method of claim 10, wherein said adapted fragments further comprise exogenous UIDs.
